Company Directory > CRO > THINQ Pharma-CRO Ltd
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of THINQ Pharma-CRO Ltd and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
THINQ Pharma-CRO Ltd is a pharmaceutical services company specializing in contract research, formulation development, and manufacturing. The company provides tailored solutions including regulatory affairs, API development, clinical dosing, and analytical services to support both emerging and established pharmaceutical firms. With a focus on generic and NCE (New Chemical Entity) formulation development, the company operates cGMP-compliant R&D facilities. They are known for their expertise in proof-of-concept products, non-infringing strategies, and patent coordination, serving markets across India, Singapore, Malaysia, and South Africa.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Pharmaceutical Manufacturing & Contract R&D
SIZE & FINANCIALS
Employees:101-200
Revenue:$30M-$40M
Founded:1989
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Polyherbal
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various regional pharmaceutical companies in Singapore, Malaysia, and South Africa
COMPETITION
Position:Niche Player
Competitors:Lupin, USV Limited, Alkem Laboratories
LEADERSHIP
Key Executives:
Vaijayanti Deshmukh - Vice President - Technical
LINKS
Website:thinqcro.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with THINQ Pharma-CRO Ltd. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.